Induction of tolerance is an effective strategy to prevent transplantation rejection and autoimmunity. Apoptotic deletion of T cells is a major mechanism utilized by both the central (thymus) and peripheral immune system to establish tolerance to self-antigens. Therefore, understanding the mechanisms regulating T cell apoptosis is critical for the development of therapeutic strategies for tolerance induction. PKC-? (protein kinase C) selectively mediates T cell receptor (TCR) signals that control T cell survival and activation. Highly specific PKC- ? inhibitors are thus believed to be able to prevent T cell-dependent allograft rejection. The objective of this application is to study PKC-? function using a highly reliable cardiac allograft rejection model, and to develop PKC-?-based therapeutic allograft rejection prevention strategies. Based on the knowledge learned from the studies, we expect to develop PKC-?-based comprehensive treatments for prevention of allograft rejection. It is also expected that such treatments will have a broader applicability in the prevention of T cell-mediated autoimmunity, such as rheumatoid arthritis and systematic lupus erythematosus. In addition, the research has significance to basic T cell biology, as it is expected to reveal novel molecular mechanisms responsible for PKC-?-regulated T cell apoptosis and PKC-8 compensatory mechanisms.

Public Health Relevance

This proposal is to study the mechanisms responsible for PKC-?-regulated immune responses in vivo using an acute cardiac allograft rejection model.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
High Priority, Short Term Project Award (R56)
Project #
1R56AI072554-01A2
Application #
8123649
Study Section
Special Emphasis Panel (ZRG1-IMM-B (02))
Program Officer
Kehn, Patricia J
Project Start
2010-09-01
Project End
2012-08-31
Budget Start
2010-09-01
Budget End
2012-08-31
Support Year
1
Fiscal Year
2010
Total Cost
$415,000
Indirect Cost
Name
City of Hope/Beckman Research Institute
Department
Type
DUNS #
027176833
City
Duarte
State
CA
Country
United States
Zip Code
91010
Ma, Jian; Wang, Ruiqing; Fang, Xianfeng et al. (2012) ?-catenin/TCF-1 pathway in T cell development and differentiation. J Neuroimmune Pharmacol 7:750-62
Kwon, Myung-Ja; Ma, Jian; Ding, Yan et al. (2012) Protein kinase C-? promotes Th17 differentiation via upregulation of Stat3. J Immunol 188:5887-97
Ma, Jian; Ding, Yan; Fang, Xianfeng et al. (2012) Protein kinase C-? inhibits inducible regulatory T cell differentiation via an AKT-Foxo1/3a-dependent pathway. J Immunol 188:5337-47
Fang, Xianfeng; Wang, Ruiqing; Ma, Jian et al. (2012) Ameliorated ConA-induced hepatitis in the absence of PKC-theta. PLoS One 7:e31174
Wang, Ruiqing; Xie, Huimin; Huang, Zhaofeng et al. (2011) Transcription factor network regulating CD(+)CD8(+) thymocyte survival. Crit Rev Immunol 31:447-58
Ma, Jian; Wang, Ruiqing; Fang, Xianfeng et al. (2011) Critical role of TCF-1 in repression of the IL-17 gene. PLoS One 6:e24768
Wang, Ruiqing; Xie, Huimin; Huang, Zhaofeng et al. (2011) T cell factor 1 regulates thymocyte survival via a ROR?t-dependent pathway. J Immunol 187:5964-73
Kwon, Myung-Ja; Wang, Ruiqing; Ma, Jian et al. (2010) PKC-? is a drug target for prevention of T cell-mediated autoimmunity and allograft rejection. Endocr Metab Immune Disord Drug Targets 10:367-72